Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Q32 Bio Inc (QTTB)

  • Technical Exchange News
  • May 28, 2025, 01:58 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Intensity Therapeutics Inc (INTS)

  • Technical Exchange News
  • May 28, 2025, 01:57 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Femasys Inc (FEMY)

  • Technical Exchange News
  • May 28, 2025, 01:57 UTC
  • 13

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Technical Exchange News
  • May 28, 2025, 01:57 UTC
  • 14

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Alto Ingredients Inc (ALTO)

  • Technical Exchange News
  • May 28, 2025, 01:57 UTC
  • 14

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Q32 Bio Inc (QTTB)

  • Technical Exchange News
  • May 27, 2025, 18:35 UTC
  • 14

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Intensity Therapeutics Inc (INTS)

  • Technical Exchange News
  • May 27, 2025, 18:35 UTC
  • 13

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Femasys Inc (FEMY)

  • Technical Exchange News
  • May 27, 2025, 18:34 UTC
  • 14

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Technical Exchange News
  • May 27, 2025, 18:34 UTC
  • 13

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Alto Ingredients Inc (ALTO)

  • Technical Exchange News
  • May 27, 2025, 18:34 UTC
  • 13

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Search

News categories

  • Technical Exchange News(9417)
  • Event(407)
  • SEC News(154536)
  • FDA Approval(8863)
  • Company Report(721)
  • Business News(105219)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin